Endo Axiom begins first human dosing of oral insulin nanoparticles for type 1 diabetes. Phase Ia trial shows breakthrough in ...

Teva Pharmaceutical refinances $4.9B debt, retiring high-coupon notes up to 8.125%. Learn how the pharma giant extends its maturity profile and ...

IMUNON partners with National Cancer Institute to advance IMNN-001 IL-12 immunotherapy beyond ovarian cancer. NCI assumes ...

Yarrow Bioscience secures $150M funding to advance first-in-class Graves' disease antibody into Phase II trials. Latest ...

NeuroHarmonics begins first patient trial of non-invasive deep-brain ultrasound for essential tremor. MHRA cleared. Learn ...

Johns Hopkins receives $2.5 million NIH grant to study TLR4's role in necrotizing enterocolitis. Discover breakthrough ...

FDA pushes zanzalintinib decision to March 2027. Exelixis' colorectal cancer drug review extended by 3 months. Latest updates ...

Navion Neurosciences secures $10.8M seed funding for precision sodium-channel medicines targeting genetic epilepsy and ...

Swedish Orphan Biovitrum receives FDA Fast Track Designation for pacritinib (Vonjo) treating VEXAS syndrome. Learn what this ...

Ethris GmbH secures €30M EIB financing for broad-spectrum nasal antiviral trials. mRNA respiratory treatment advances to ...

CONNECTA Therapeutics secures €3.1M funding to advance CTH120, a TrkB modulator, into mid-stage trials for Fragile X syndrome ...

Third Arc Bio selects lead candidate for masked CD3 T cell engager under expanded Adagene collaboration. Milestone payments ...